-
Je něco špatně v tomto záznamu ?
Valproic acid decreases the reparation capacity of irradiated MOLT-4 cells
D. Muthna, J. Vavrova, E. Lukasova, A. Tichy, J. Knizek, R. Kohlerova, N. Mazankova, M. Rezacova
Jazyk angličtina Země Rusko
Typ dokumentu časopisecké články, práce podpořená grantem
Odkazy
PubMed
22642109
Knihovny.cz E-zdroje
- MeSH
- apoptóza účinky léků účinky záření MeSH
- fosforylace účinky léků účinky záření MeSH
- histony genetika metabolismus MeSH
- inhibitory enzymů farmakologie MeSH
- kyselina valproová farmakologie MeSH
- leukemie metabolismus MeSH
- lidé MeSH
- nádorové buněčné linie MeSH
- nádorový supresorový protein p53 genetika metabolismus MeSH
- oprava DNA účinky léků MeSH
- poškození DNA účinky léků účinky záření MeSH
- protoonkogenní proteiny c-mdm2 genetika metabolismus MeSH
- radiosenzibilizující látky farmakologie MeSH
- regulace genové exprese účinky léků účinky záření MeSH
- rho proteiny vázající GTP genetika metabolismus MeSH
- záření gama MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
The aim of our work was to evaluate mechanisms leading to radiosensitization of MOLT-4 leukemia cells following valproic acid (VA) treatment. Cells were pretreated with 2 mM VA for 24 h followed by irradiation with a dose of 0.5 or 1 Gy. The effect of both noxae, alone and combined, was detected 1 and 24 hours after the irradiation. Induction of apoptosis was evaluated by a flow cytometry. The extent of DNA damage was further determined by phosphorylation of histone H2AX using confocal microscopy. Changes in protein expression were identified by SDS-PAGE/immunoblotting. Two-millimolar VA increased apoptosis induction after irradiation as well as phosphorylation of H2AX and provokes an increase in the level of p53 and its phosphorylation at Ser392 in 4 h post-irradiation. Likewise, p21 protein reached its maximal expression in 4 h after the irradiation of VA-treated cells. Twenty four hours later, only the p53 phosphorylated at Ser15 was detected. At the same time, the protein mdm2 (negative regulator of p53) was maximally activated. The 24-hour treatment of MOLT-4 leukemia cells with 2 mM VA results in radiosensitizing, increases apoptosis induction, H2AX phosphorylation, and also p53 and p21 activation.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12034472
- 003
- CZ-PrNML
- 005
- 20200505133211.0
- 007
- ta
- 008
- 121023s2012 ru f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)22642109
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ru
- 100 1_
- $a Záškodová, Darina. $7 xx0305436 $u Department of Medical Biochemistry, Faculty of Medicine in Hradec Kralove, Charles University in Prague, Czech Republic
- 245 10
- $a Valproic acid decreases the reparation capacity of irradiated MOLT-4 cells / $c D. Muthna, J. Vavrova, E. Lukasova, A. Tichy, J. Knizek, R. Kohlerova, N. Mazankova, M. Rezacova
- 520 9_
- $a The aim of our work was to evaluate mechanisms leading to radiosensitization of MOLT-4 leukemia cells following valproic acid (VA) treatment. Cells were pretreated with 2 mM VA for 24 h followed by irradiation with a dose of 0.5 or 1 Gy. The effect of both noxae, alone and combined, was detected 1 and 24 hours after the irradiation. Induction of apoptosis was evaluated by a flow cytometry. The extent of DNA damage was further determined by phosphorylation of histone H2AX using confocal microscopy. Changes in protein expression were identified by SDS-PAGE/immunoblotting. Two-millimolar VA increased apoptosis induction after irradiation as well as phosphorylation of H2AX and provokes an increase in the level of p53 and its phosphorylation at Ser392 in 4 h post-irradiation. Likewise, p21 protein reached its maximal expression in 4 h after the irradiation of VA-treated cells. Twenty four hours later, only the p53 phosphorylated at Ser15 was detected. At the same time, the protein mdm2 (negative regulator of p53) was maximally activated. The 24-hour treatment of MOLT-4 leukemia cells with 2 mM VA results in radiosensitizing, increases apoptosis induction, H2AX phosphorylation, and also p53 and p21 activation.
- 650 _2
- $a apoptóza $x účinky léků $x účinky záření $7 D017209
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a poškození DNA $x účinky léků $x účinky záření $7 D004249
- 650 _2
- $a oprava DNA $x účinky léků $7 D004260
- 650 _2
- $a inhibitory enzymů $x farmakologie $7 D004791
- 650 _2
- $a záření gama $7 D005720
- 650 _2
- $a regulace genové exprese $x účinky léků $x účinky záření $7 D005786
- 650 _2
- $a histony $x genetika $x metabolismus $7 D006657
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a leukemie $x metabolismus $7 D007938
- 650 _2
- $a fosforylace $x účinky léků $x účinky záření $7 D010766
- 650 _2
- $a protoonkogenní proteiny c-mdm2 $x genetika $x metabolismus $7 D051736
- 650 _2
- $a radiosenzibilizující látky $x farmakologie $7 D011838
- 650 _2
- $a nádorový supresorový protein p53 $x genetika $x metabolismus $7 D016159
- 650 _2
- $a kyselina valproová $x farmakologie $7 D014635
- 650 _2
- $a rho proteiny vázající GTP $x genetika $x metabolismus $7 D020741
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Vávrová, Jiřina, $d 1946- $u Department of Medical Biochemistry, Charles University in Prague, Faculty of Medicine in Hradec Králové, Hradec Králové, Czech Republic $7 xx0004363
- 700 1_
- $a Lukášová, Emilie $u Institute of Biophysics, Academy of Sciences of the Czech Republic, Czech Republic $7 xx0064040
- 700 1_
- $a Tichý, Aleš, $d 1980- $u Department of Medical Biochemistry, Charles University in Prague, Faculty of Medicine in Hradec Králové, Šimkova 870, 500 38 Hradec Králové, Czech Republic; Department of Radiobiology, Faculty of Military Health Sciences, University of Defence, Hradec Králové, Czech Republic $7 xx0135624
- 700 1_
- $a Knížek, Jiří $u Dept. of Medical Biochemistry, Faculty of Medicine in Hradec Kralove, Simkova 870, 500 38 Hradec Kralove, Czech Republic $7 xx0105843
- 700 1_
- $a Köhlerová, Renata. $u Department of Medical Biochemistry, Faculty of Medicine in Hradec Králové, Charles University in Prague, Czech Republic $7 xx0021768
- 700 1_
- $a Mazánková, Naděžda. $u Department of Medical Biochemistry, Charles University in Prague, Faculty of Medicine in Hradec Králové, Hradec Králové, Czech Republic $7 _AN029617
- 700 1_
- $a Řezáčová, Martina, $d 1972- $u Department of Medical Biochemistry, Charles University in Prague, Faculty of Medicine in Hradec Králové, Hradec Králové, Czech Republic $7 nlk20020124956
- 773 0_
- $w MED00003402 $t Molekuliarnaia biologiia $x 0026-8984 $g Roč. 46, č. 1 (2012), s. 122-128
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22642109 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20121023 $b ABA008
- 991 __
- $a 20200505133210 $b ABA008
- 999 __
- $a ok $b bmc $g 956482 $s 791969
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 46 $c 1 $d 122-128 $i 0026-8984 $m Molekuljarnaja biologija $n Mol Biol $x MED00003402
- LZP __
- $b NLK112 $a Pubmed-20121023